Literature DB >> 15870382

Development of age-dependent glomerular lesions in galectin-3/AGE-receptor-3 knockout mice.

Carla Iacobini1, Giovanna Oddi, Stefano Menini, Lorena Amadio, Carlo Ricci, Clelia Di Pippo, Mariella Sorcini, Flavia Pricci, Francesco Pugliese, Giuseppe Pugliese.   

Abstract

Aging is characterized by renal functional and structural abnormalities resembling those observed in diabetes. These changes have been related to the progressive accumulation of advanced glycation end-products (AGEs) and cumulative oxidative stress occurring in both conditions. We previously reported that galectin-3 ablation is associated with increased susceptibility to diabetes- and AGE-induced glomerulopathy, thus indicating a protective role of galectin-3 as an AGE receptor. To investigate the role of the AGE/AGE receptor pathway in the pathogenesis of age-related renal disease, we evaluated the development of glomerular lesions in aging galectin-3 knockout (KO) vs. wild-type (WT) mice and their relation to the increased AGE levels and oxidative stress characterizing the aging process. KO mice showed significantly more pronounced age-dependent increases in proteinuria, albuminuria, glomerular sclerosis, and glomerular and mesangial areas, starting at 18 mo, as well as renal extracellular matrix mRNA and protein expression, starting at 12 mo vs. age-matched WT mice. Circulating and renal AGEs, plasma isoprostane 8-epi-PGF2alpha levels, glomerular content of the glycoxidation and lipoxidation products N(epsilon)-carboxymethyllysine and 4-hydroxy-2-nonenal, and renal nuclear factor-kappaB activity also increased more markedly with age in KO than WT mice. AGE levels correlated significantly with renal functional and structural parameters. These data indicate that aging galectin-3 KO mice develop more pronounced changes in renal function and structure than coeval WT mice, in parallel with a more marked degree of AGE accumulation, oxidative stress, and associated low-grade inflammation, thus supporting the concept that the AGE/AGE receptor pathway is implicated in age-related renal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870382     DOI: 10.1152/ajprenal.00435.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  18 in total

Review 1.  Inflammation and insulin resistance: New targets encourage new thinking: Galectin-3 and LTB4 are pro-inflammatory molecules that can be targeted to restore insulin sensitivity.

Authors:  Andrew M F Johnson; Shaocong Hou; Pingping Li
Journal:  Bioessays       Date:  2017-07-28       Impact factor: 4.345

2.  Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease.

Authors:  M Butscheid; P Hauptvogel; P Fritz; U Klotz; D M Alscher
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

3.  Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease.

Authors:  Miliyun G Chiu; Tanya M Johnson; Adrian S Woolf; Eugenia M Dahm-Vicker; David A Long; Lisa Guay-Woodford; Katherine A Hillman; Suleman Bawumia; Kerrie Venner; R Colin Hughes; Francoise Poirier; Paul J D Winyard
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 4.  Galectin-3 in autoimmunity and autoimmune diseases.

Authors:  Felipe L de Oliveira; Mariele Gatto; Nicola Bassi; Roberto Luisetto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-03

5.  Galectin-3 is a new MerTK-specific eat-me signal.

Authors:  Nora B Caberoy; Gabriela Alvarado; Jo-Lawrence Bigcas; Wei Li
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

6.  Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis.

Authors:  Daryl M Okamura; Katie Pasichnyk; Jesus M Lopez-Guisa; Sarah Collins; Daniel K Hsu; Fu-Tong Liu; Allison A Eddy
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-20

Review 7.  Of cardiovascular illness and diversity of biological response.

Authors:  Pascal J Goldschmidt-Clermont; Chunming Dong; Mike West; David M Seo
Journal:  Trends Cardiovasc Med       Date:  2008-07       Impact factor: 6.677

8.  Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function.

Authors:  Davina H Rhodes; Maria Pini; Karla J Castellanos; Trinidad Montero-Melendez; Dianne Cooper; Mauro Perretti; Giamila Fantuzzi
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

9.  Cell cycle arrest in a model of colistin nephrotoxicity.

Authors:  Michael T Eadon; Bradley K Hack; Jessy J Alexander; Chang Xu; M Eileen Dolan; Patrick N Cunningham
Journal:  Physiol Genomics       Date:  2013-08-06       Impact factor: 3.107

10.  Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.

Authors:  Karly C Sourris; Anna Watson; Karin Jandeleit-Dahm
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.